Target intelligence / Profile preview

Eukaryotic Initiation Factor 4A (eIF4A)

Target
eIF4A
Molecular classification
Enzyme, DEAD-box RNA helicase
01

Overview

Eukaryotic initiation factor 4A (eIF4A) is a family of highly conserved RNA helicases essential for the initiation phase of eukaryotic translation. The eIF4A family in humans consists of three closely related proteins: EIF4A1, EIF4A2, and EIF4A3. These proteins are required for the binding of mRNA to the 40S ribosomal subunit and function primarily by unwinding double-stranded regions within mRNA molecules. eIF4A acts as an ATP-dependent RNA helicase that unwinds secondary structures in the 5′-untranslated region (UTR) of mRNAs, facilitating ribosome scanning to locate the start codon during translation initiation. It is a core component of the eIF4F complex, which also includes eIF4E (the cap-binding protein) and eIF4G (a scaffolding protein). Because it regulates gene expression at translational level—especially under stress or disease conditions—eIF4A has become a target for therapeutic intervention in cancer and viral infections where aberrant protein synthesis occurs.

Other names
EIF4A1EIF4A2EIF4A3
02

Mechanism of action

Inhibition of RNA helicase activity

03

Biological functions

Translation initiationmRNA unwindingRibosome scanning
04

Disease associations

CancerViral infections

Beyond the preview

Go deeper on Eukaryotic Initiation Factor 4A (eIF4A).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Eukaryotic Initiation Factor 4A (eIF4A).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call